Tansuphaswadikul S, Aung SE, Phonrat B, Kaewkungwal J, Pitisuttithum P, Maek-a-nantawat W. Predisposing factors for nevirapine toxicity among AIDS patients with low baseline CD4 count.Asian Pac J Allergy Immunol. 2007 Jun-Sep;25(2-3):147-54.

Osmanov S, Ackland J, Allen S, Barth-Jones D, Birx D, Chomba E, Churchyard G, Duerr A, Jin SG, Johnston M, Fast PE, Fix A, Foulkes M, Follmann D, Hutubessy R, Malone S, Gray R, Indrayan A, Levin J, Mathieson BJ, Mastro TD, McNeil J, Pitisuttithum P, et al. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York , USA . Aids 2007; 21(4):539-46.

Tansuphasawadikul S, Saito W, Kim J, Phonrat B, Dhitivat J, Chamnachanan S, Pitisuttithum P. Outcomes in HIV-Infected Patients on Antiretroviral Therapy with Tuberculosis.Southeast Asian J Trop Med Public Health 2007; 38(6):1053-1060

Pitisuttithum P, Choopanya K, Bussaratid V, Vanichseni S, Griensven FV, Phonrat B, Martin M, Vimutsunthorn E, Sangkum U, Kitayaporn D, Tappero JW, Heyward W, Francis D. Social Harms in Injecting Drug Users Participating in the First Phase III HIV Vaccine Trial in Thailand. J Med Assoc Thai 2007; 90 (11): 2441-2448

Pitisuttithum P. Thailand’s eExperiences in Conducting HPV Vaccine Trials and HPV Vaccine Update (Abstract). National Cancer Conference, Bangkok, Thailand, December 12-14, 2007 p.47

Hammer S, Miller M, Pape J, Pitisuttithum P, Suriyanon V, Nitayaphan S, Sanchez J, Kallas E, Harro C, Gray G, Cadinali M, Turner K, Sun X, Mehrotra D, Quirk E. Safety and immunogenicity of the MRKAd5 gag HIV-1 vaccine in a worldwide phase I study of healthy adults (Merck V520-018/HVTN 050) (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.59

Premsri N, Namwat C, Rerks-Ngarm S, Kunasol P, Khamboonreaung C, Chunsuttiwat S, Wattana S, Wiriyakijja W, Kim JH, Benenson MW, Pitisuttithum P, Nittayaphan S. Integration of community engagement activities support the prime-boost phase III HIV vaccine trial in Thailand (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.85

Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal J, Nitayaphan S, Khamboonruang C, Kunasol P, Benenson M, Kim J. Women participation in the phase III efficacy trial of ALVAC HIV-1 vaccine priming, AIDSVAX vaccine boosting in Thailand (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.92

Rerks-Ngarm S, Chunsuttiwat S, Pitisuttithum P, Nittayaphan S, Kaewkungwal J, Kim JH, Wattana S, Wiriyakijja W, Thongchareon P, Kunasol P, Khamboonreaung C. Thai Prime-boost HIV vaccine phase III trial: update 2007 (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.102

Namwat C, Morgan P, Premsri N, Debyasuvarn T, Pitisuttithum P, Bussaratid V, Benenson M, Kim JH. Social Impact of participation in a phase III HIV vaccine trial in Thailand (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.105

Paris RM, Bejrachandra S, Thongcharoen P, Nitayaphan S, Suriyanon V, Pitisuttithum P, Sambor A, Barnett S, Gurunathan S, Gurwith M, Kim S, MS de Souza, Polonis VR, Kim JH. HLA Class II alleles and neutralizing antibody responses to HIV-1 protein subunit boosting in a Thai population (Abstract). AIDS VACCINE 2007, Seattle, USA, August 20-23, 2007 p.135

Saito W,  Pitisuttithum P, Tansuphasawadikul S, Dhitivat J, Phonrat B, Chamnachanan S, Kim J. Outcome of Tuberculosis in Advanced HIV-Infected Patients on Antiretroviral Therapy (Abstract). IAS 2007, Sydney, Australia, July 22-25, 2007.

Home